| Titre : | Cancer/Radiothérapie, vol. 26, no. 4 - Juin 2022 |
| Type de document : | Bulletin : Périodique |
| Paru le : | 01/06/2022 |
| Année de publication : | 2022 |
| Langues: | Français |
| Disponible en ligne : | Non |
Dépouillements
Article
S. Allali ;
V. Servois ;
A. Beddok ;
A. Fourquet ;
Y. Kirova
|
Purpose The coronavirus disease 2019 (covid-19) caused by the severe acute respiratory syndrome coronavirus 2 (Sars-Cov-2) is at the origin of a global pandemic. This pandemic has prompted the current health system to reorganize and rethink the [...]
Article
I. Chaffai ;
K. Cao ;
M. Kissel ;
R. El Ayachy ;
A. Aboudaram ;
A. Fourquet ;
Y. Kirova
|
Objectif de l’étude
La radiothérapie hypofractionnée modérée est devenue une pratique de routine pour une population sélectionnée de patientes traitées pour un cancer du sein de stade précoce. En avril 2020 est publiée l’étude Fast Forward qui [...]
Article
Re-irradiation of pelvic recurrent gynecological cancer is a challenge due to the proximity of high-radiation-sensitive organs, such as the bowel and the urinary tract. Hadrontherapy for re-irradiation emerges as a safe and effective treatment w[...]
Article
Radiotherapy remains an important treatment modality for patients with chest malignancies; this is particularly true in patients with breast cancer and Hodgkin lymphoma as well as lung, esophageal, and other mediastinal tumors. More than half of[...]
Article
V. Chiesa ;
R. Sun ;
G. Brusadin ;
M.-S. Bour ;
S. Corbin
|
Objectif de l’étude
L’épidémie de coronavirus (coronavirus disease 2019 [COVID-19]) continue de se propager de manière exponentielle dans le monde. Les patients atteints de cancer ont des risques de comorbidité plus élevés que le reste de la po[...]
Article
Béatrice Lognos ;
Murielle Glondu-Lassis ;
Pierre Senesse ;
Marian Gutowski ;
William Jacot ;
Claire Lemanski ;
Michel Amouyal ;
David Azria ;
Estelle Guerdoux ;
Céline Bourgier
|
La radiothérapie adjuvante est l’un des principaux traitements oncologiques des cancers du sein localisés. Les patientes traitées par radiothérapie peuvent voir se développer des effets indésirables aigus et tardifs. La gestion médicale de ceux-[...]
Article
N. Demogeot ;
Julia Salleron ;
V. Beckendorf ;
D. Peiffert ;
M. Levitchi ;
C. Charra-Brunaud ;
S. Renard
|
Purpose The standard treatment for endometrial cancer is surgery, although depending on the risk factors, adjuvant radiation therapy may also be given. It is proposed for high-risk carcinomas for which an improvement in progression-free survival[...]
Article
R. Avgousti ;
C. Antypas ;
C. Armpilia ;
F. Simopoulou ;
Z. Liakouli ;
P. Karaiskos ;
V. Kouloulias ;
E. Kyrodimos ;
L.A. Moulopoulos ;
A. Zygogianni
|
Purpose To identify from the current literature when is the right time to replan and to assign thresholds for the optimum process of replanning. Nowadays, adaptive radiotherapy (ART) for head and neck cancer plays an exceptional role consisting [...]
Article
Dong-Cheng He ;
Zhi-Jian Zhu ;
Xiao-Ye Zhang ;
Yan Zhang ;
Jun Hong ;
Ting-Ting Shi ;
Ji-Hua Han
|
Purpose To compare the dosimetric differences between intensity modulated radiation therapy (IMRT) and volumetric modulated arc therapy (VMAT) in the treatment of male and female thymoma. Material and methods This single-institutional analysis i[...]
Article
Z.-P. Liu ;
Q.-Y. Song ;
C.-L. Chu ;
S.-H. Liu ;
Y.-X. Ren ;
J. Chen ;
Daxin Zhang
|
Purpose To explore the potential protective effect of Kanglaite injection against radiotherapy-induced mucositis in patients with head and neck cancer. Patients and methods This was an open-label, single-arm, and phase II trial. The primary endp[...]
Article
Purpose Surface-guided radiotherapy is useful for the pre-positioning and monitoring of radiotherapy. The purpose of this study was to investigate the impact of surface guidance on the repeatability of patient localization and to estimate the sp[...]
Article
S. Allali ;
F. Chasset ;
Y. Kirova ;
C. Saint-Martin ;
P. Moguelet ;
A. Fourquet ;
A. Beddok
|
Data on the incidence and severity of radiation-induced toxicity in patients with systemic and/or cutaneous lupus erythematosus (SLE/CLE) are very limited. After reporting the case of a patient who experienced major toxicity and CLE flare in the[...]
Article
S. Sumodhee ;
V. Atallah ;
R. Kinj ;
J. Doyen ;
B. L’Homel ;
P. Gillon ;
P. Paquis ;
F. Almairac ;
S. Hieronimus ;
R. Schiappa ;
J.-L. Sadoul ;
D. Sumodhee ;
N. Pontikos ;
Q. Richier ;
Jean-Michel Hannoun-Lévi ;
C. Scouarnec ;
N. Chevalier ;
P.-Y. Bondiau
|
Purpose Evaluate efficacy and toxicity of hypofractionated stereotactic radiotherapy (HSRT) for patients treated for pituitary adenoma (PA) with an alternative HSRT escalating protocol delivering 35Gy in 5 fractions. Material and methods From Ju[...]
Article
In order to provide more convenient irradiation regimens for patient comfort, radiation facility organization and health expenses, new hypofractionated protocols have been evaluated. Moderately (dose/fraction: 2.3 to 3Gy), then ultra (dose/fract[...]
Article
G. Crehange ;
F. Goudjil ;
S.-L. Krhili ;
M. Minsat ;
L. de Marzi ;
R. Dendale
|
En raison des propriétés physiques de la radiothérapie par faisceau de protons (PT), qui permet de déposer l’énergie à une profondeur spécifique avec une chute rapide de la dose au-delà de cette profondeur, la protonthérapie présente plusieurs a[...]
